In Novo Nordisk’s randomized clinical trial, semaglutide reduced the risk for major adverse cardiovascular events by 14% ...

Politicians seek more involuntary treatment of homeless people with mental illness and addiction, but experts object to this ...

Researchers conducted a retrospective analysis to identify the specific population of patients with TNBC that benefited from ...

SAVANNAH, Georgia — A new clinical education tool aims to speed the diagnosis of amyotrophic lateral sclerosis (ALS), which ...

High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...

More than 90% of patients with PsA who received guselkumab every 8 weeks in the DISCOVER-2 trial maintained minimal ...

Data from the Cohort of Cardiovascular Diseases in Pregnancy (CONCEPTION), a French prospective national cohort study, ...

Up to 100% of ritlecitinib responders sustained hair regrowth and 30% of nonresponders achieved results at week 48 with ...

The findings suggested that higher doses of vitamin D3 supplementation do not reduce markers of subclinical cardiovascular ...

Pediatric MG is rare. Cases in children are estimated to account for 10% of MG cases diagnosed each year. According to a 2020 ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only ...